Literature DB >> 7936568

High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant.

J W Karesh1, S C Dresner.   

Abstract

BACKGROUND: High-density porous polyethylene (Medpor) has been used successfully as an implant in orbital fracture repair and in the management of both cosmetic and post-traumatic facial deformities. The material is well tolerated, resists infection, is nonantigenic, and promotes tissue ingrowth. Additionally, sutures can be passed through it. These characteristics led to its use as an implant in anophthalmic socket surgery.
METHODS: Twenty-one patients with anophthalmia underwent implantation of spherically shaped high-density porous polyethylene implants. The implant was used in six primary enucleations with direct extraocular muscle attachment, ten secondary implant insertions, one repeat secondary implant insertion, and five eviscerations.
RESULTS: Postoperative follow-up averaged 19 months. During this period, there were no extrusions, infections, significant inflammatory responses, or implant exposures. One implant was removed 4 months after insertion due to inadequate initial placement secondary to a severe post-traumatic orbital deformity. Successful re-implantation was performed without complication. Postoperatively, all sockets showed good to excellent motility. Results of histologic examination of the removed implant demonstrated minimal inflammatory response and extensive fibrovascular ingrowth involving 60% of the implant substance.
CONCLUSIONS: This initial report indicates that high-density porous polyethylene can be used successfully as an implant in anophthalmic socket surgery. Its advantages over other similar implants include a significantly lower material cost and the ability to suture the extraocular muscles directly to it without the need for a covering material such as fascia or sclera. Experimental studies are in progress to determine if this implant can be integrated with an ocular prosthesis to promote improved motility and cosmesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936568

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  [New ceramic materials for use in anophthalmia surgery].

Authors:  P Y Robert; J Rulfi; J P Adenis
Journal:  Ophthalmologe       Date:  2003-06-18       Impact factor: 1.059

2.  Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure.

Authors:  M S Sagoo; J M Olver
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Amniotic membrane transplantation for porous sphere orbital implant exposure.

Authors:  Yan-hong Chen; Hong-guang Cui
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

4.  [Porous orbital implants].

Authors:  B Cleres; H W Meyer-Rüsenberg
Journal:  Ophthalmologe       Date:  2014-06       Impact factor: 1.059

Review 5.  Integrated versus non-integrated orbital implants for treating anophthalmic sockets.

Authors:  Silvana Schellini; Regina El Dib; Leandro Re Silva; Joyce G Farat; Yuqing Zhang; Eliane C Jorge
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

6.  A survey of satisfaction in anophthalmic patients wearing ocular prosthesis.

Authors:  Jong-Suk Song; Jaeryung Oh; Se Hyun Baek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-17       Impact factor: 3.117

7.  Four petals evisceration for atrophia bulbi.

Authors:  Molham A Elbakary
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

8.  Actinomyces infection in porous polyethylene orbital implant.

Authors:  Z A Karcioglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-07       Impact factor: 3.117

9.  The survival of freely grafted orbital fat on porous polyethylene orbital implants in the rabbit.

Authors:  Nam Ju Kim; Ho Kyung Choung; Sang In Khwarg
Journal:  Korean J Ophthalmol       Date:  2006-09

10.  The use of porous polyethylene (Medpor) lower eyelid spacers in lid heightening and stabilisation.

Authors:  J Tan; J Olver; M Wright; R Maini; C Neoh; A J Dickinson
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.